Skip to content

Study on the Effect of Ostikot Forte Tablet in Knee Joint Pain due to Osteoarthritis

Effectiveness of Ostikot Forte Tablet in Osteoarthritis of Knee joint -A Quasi- Experimental Study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096034
Enrollment
32
Registered
2025-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

The managing trustee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants with knee joint pain satisfying the diagnostic criteria

Exclusion criteria

Exclusion criteria: 1.History of rheumatoid arthritis or other inflammatory joint diseases 2.Known case of Malignancy 3. Known Cardiovascular disorders (such as Coronary artery disease, Rheumatic heart disease, congenital heart disease and Cardiac myopathy) 4. Known Hepatic disorders and Endocrinal disorders 5. Pregnant and lactating females 6. Any other condition that may jeopardize the study

Design outcomes

Primary

MeasureTime frame
Pain Reduction: Measured using the Visual Analog Scale (VAS) for pain at baseline & after 2 weeks, 1 month and 3monthsTimepoint: 90days

Secondary

MeasureTime frame
Joint Function & Mobility: Assessed using the WOMAC Index 9(Western Ontario & McMaster Universities Osteoarthritis Index)- at baseline & after 2 weeks, 1 month & after 3 months Blood test – Calcium blood test, blood vitamin D TEST - at baseline & after 1 month BMD test - at baseline & after 3 months Timepoint: 14days

Countries

India

Contacts

Public ContactDr Anoop AK

Vaidyaratnam P S Variers Aryavaidyasala Kottakkal

researchmarketing@aryavaidyasala.com04832806520

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026